Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.24
+0.11 (1.35%)
At close: Nov 20, 2024, 4:00 PM
8.25
+0.01 (0.12%)
Pre-market: Nov 21, 2024, 4:32 AM EST
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $1.18 billion as of November 21, 2024. Its market cap has decreased by -0.90% in one year.
Market Cap
1.18B
Enterprise Value
919.41M
1-Year Change
-0.90%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $1.18B, an increase of 840.08%. That is a compound annual growth rate of 24.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.16B | -9.84% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mesoblast | 1.19B |
| Tilray Brands | 1.18B |
| CareDx | 1.18B |
| Arcutis Biotherapeutics | 1.18B |
| Maravai LifeSciences Holdings | 1.17B |
| Progyny | 1.16B |
| Ardelyx | 1.13B |
| Artivion | 1.13B |